What are the mechanism of action and side effects of T. Practin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mechanism of Action and Side Effects of T. Practin

T. Practin (cyproheptadine) is an antihistamine with anticholinergic and antiserotonergic properties that acts primarily as a first-generation H1 receptor antagonist and serotonin antagonist, commonly used for appetite stimulation, allergic conditions, and as an adjunct in certain hematological disorders.

Mechanism of Action

Cyproheptadine works through multiple pharmacological actions:

  1. H1-receptor antagonism: Blocks histamine H1 receptors, reducing allergic symptoms
  2. Serotonin (5-HT) antagonism: Blocks serotonin receptors, particularly 5-HT2 receptors
  3. Anticholinergic effects: Blocks muscarinic acetylcholine receptors
  4. Calcium channel blocking activity: Mild calcium channel antagonism

Clinical Applications

  • Appetite stimulation: Particularly useful in underweight patients or those with appetite loss
  • Allergic conditions: Urticaria, pruritus, and other allergic manifestations
  • Adjunctive therapy in hematological disorders: Used in immune thrombocytopenia (ITP) as a second-line agent

Side Effects

Common Side Effects

  • Gastrointestinal effects: Nausea, diarrhea, abdominal pain, vomiting 1
  • Anticholinergic effects:
    • Dry mouth
    • Blurred vision
    • Urinary retention
    • Constipation
  • CNS effects:
    • Drowsiness/sedation (most common)
    • Dizziness
    • Headache
    • Confusion (especially in elderly)

Less Common Side Effects

  • Weight gain: Due to increased appetite and metabolic effects
  • Excitation/paradoxical stimulation: Particularly in children
  • Hypersensitivity reactions: Skin rashes, photosensitivity

Rare but Serious Side Effects

  • Hepatotoxicity: Elevated liver enzymes, though uncommon 1
  • Hematological effects: Rare cases of blood dyscrasias
  • Cardiovascular effects: Tachycardia, palpitations

Special Considerations

Drug Interactions

  • CNS depressants: Enhanced sedative effects when combined with alcohol, benzodiazepines, or opioids
  • Anticholinergic drugs: Additive anticholinergic effects
  • MAO inhibitors: Increased anticholinergic and CNS depressant effects
  • Warfarin/anticoagulants: May require dose adjustment as seen with similar medications 1

Contraindications

  • Angle-closure glaucoma
  • Prostatic hypertrophy
  • Severe cardiovascular disease
  • Concurrent MAO inhibitor therapy
  • Pregnancy and lactation (relative contraindication)

Dosing Considerations

  • Adults: Typically 4-20 mg daily in divided doses
  • Children: Weight-based dosing, generally lower than adult doses
  • Elderly: Lower doses recommended due to increased sensitivity to anticholinergic effects

Monitoring

  • Efficacy: Weight gain (if used as appetite stimulant), resolution of allergic symptoms
  • Side effects: Particularly sedation, anticholinergic effects, and weight gain
  • In hematological disorders: Monitor platelet counts when used as adjunctive therapy

Clinical Pearls

  • Start at lower doses to minimize sedation and anticholinergic side effects
  • Take with food to reduce gastrointestinal side effects
  • Evening dosing may be preferred if sedation is a concern or insomnia is a target symptom
  • Not recommended as first-line therapy for allergic conditions due to significant side effect profile compared to newer antihistamines

The anticholinergic and sedative properties of T. Practin make it less favorable as a first-line antihistamine compared to second-generation agents, but its unique appetite-stimulating and antiserotonergic properties make it valuable in specific clinical scenarios.

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What are the interventions for thrombotic thrombocytopenic purpura (TTP)?
Is there an association between Acute Rheumatic Fever (ARF) and Thrombotic Thrombocytopenic Purpura (TTP)?
What is the treatment for Microangiopathic Hemolytic Anemia (MAHA)?
What is the management of refractory Thrombotic Thrombocytopenic Purpura (TTP)?
What is the relationship between thrombotic thrombocytopenic purpura (TTP) and underlying conditions such as infections, pregnancy, certain medications, human immunodeficiency virus (HIV), systemic lupus erythematosus (SLE), and tumors?
What are the guidelines for hypocalcemia workup and management?
What are the clinical findings for leukoencephalopathy?
What are the available GLP-1 (Glucagon-like peptide-1) agonist brands, such as Victoza (liraglutide), Byetta (exenatide), and Trulicity (dulaglutide), in India?
What are the side effects of cyproheptadine?
What are the strategies to reduce pain from sigmoid volvulus?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question